Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy

被引:74
作者
Chantelau, E [1 ]
机构
[1] Heinrich Heine Univ, MNR Klin, Diabet Ambulanz, Dept Med, D-40001 Dusseldorf, Germany
关键词
D O I
10.1136/bjo.82.7.725
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background-Acute reduction of chronic hyperglycaemia can accelerate early diabetic retinopathy. In adolescent patients with Mauriac's syndrome, this phenomenon is related to an upregulation of subnormal serum IGF-1 levels. Aim-To obtain longitudinal data on serum IGF-I and retinopathy status in poorly controlled adult insulin dependent (type I) diabetic patients without Mauriac's syndrome, in whom hyperglycaemia is reduced by intensive insulin therapy. Methods-Four patients with chronic severe insulin deficiency and early microangiopathy were studied prospectively. Changes in plasma glucose, HbA(1c), serum IGF-I levels, proteinuria, retinopathy, and clinical status were followed up closely. Results-Reducing hyperglycaemia from >16 mmol/l (equivalent to HbA(1c) >11%) to <10 mmol/l (HbA(1c) <8%) within 5 months increased serum IGF-1. levels by 70-220%. While proteinuria and symptomatic neuropathy regressed, retinopathy progressed from the mild to the severe nonproliferative stage with maculopathy (n=4), and to the proliferative stage (n=1). Laser coagulation was commenced upon the appearance of sight threatening macular oedema (n=4). Conclusion-Upregulation of serum IGF-1 preceding retinal deterioration in these patients suggests a cause-effect relation, consistent with earlier experimental and clinical data.
引用
收藏
页码:725 / 730
页数:6
相关论文
共 39 条
  • [1] Agardh Carl-David, 1992, Journal of Diabetes and its Complications, V6, P96, DOI 10.1016/1056-8727(92)90018-G
  • [2] HYPOXIC REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN RETINAL CELLS
    AIELLO, LP
    NORTHRUP, JM
    KEYT, BA
    TAKAGI, H
    IWAMOTO, MA
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (12) : 1538 - 1544
  • [3] ALDINGTON SJ, 1995, DIABETOLOGIA, V38, P437, DOI 10.1007/BF00410281
  • [4] ALMRAYAT M, 1997, DIABETIC MED S4, V14, pS39
  • [5] Averbukh E., 1997, Diabetologia, V40, pA493
  • [6] INSULIN-LIKE GROWTH FACTOR-(IGF)-I AND FACTOR-(IGF)-II IN DIABETIC PREGNANCY - SUPPRESSION OF NORMAL PREGNANCY-INDUCED RISE OF IGF-I
    BHAUMICK, B
    DANILKEWICH, AD
    BALA, RM
    [J]. DIABETOLOGIA, 1986, 29 (11) : 792 - 797
  • [7] Intravitreal growth factors in proliferative diabetic retinopathy: Correlation with neovascular activity and glycaemic management
    Boulton, M
    Gregor, Z
    McLeod, D
    Charteris, D
    JarvisEvans, J
    Moriarty, P
    Khaliq, A
    Foreman, D
    Allamby, D
    Bardsley, B
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1997, 81 (03) : 228 - 233
  • [8] Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy
    Burgos, R
    Simo, R
    Audi, L
    Mateo, C
    Mesa, J
    GarciaRamirez, M
    Carrascosa, A
    [J]. DIABETOLOGIA, 1997, 40 (09) : 1107 - 1109
  • [9] CARROLL PB, 1992, ACTA PAEDIAT, V8, P355
  • [10] Chantelau E, 1997, BMJ-BRIT MED J, V315, P1105